Showing results (11-20 of 29) with videos related to
Sort By:
Pageof 3
Alimentary Pharmacology & Therapeutics|February 1, 1987
Omeprazole in peptic ulcers resistant to histamine H2-receptor antagonistsG N Tytgat, C B Lamers, W Hameeteman, et al.Scandinavian Journal of Gastroenterology|January 1, 1996
Cost effectiveness of medical versus surgical treatment in patients with severe or refractory gastroesophageal reflux disease in the NetherlandsG Van Den Boom, P M Go, W Hameeteman, et al.Alimentary Pharmacology & Therapeutics|April 2, 1999
Serum gastrin and chromogranin A during medium- and long-term acid suppressive therapy: a case-control studyS Sanduleanu, M Stridsberg, D Jonkers, et al.Scandinavian Journal of Gastroenterology|October 1, 1990
Five-year cimetidine maintenance trial for peptic ulcer disease. A clinical and endocrinologic approachG N Tytgat, W Hameeteman, C J Mulder, et al.Journal of Clinical Gastroenterology|August 1, 1987
Sucralfate versus cimetidine in reflux esophagitis. A single-blind multicenter studyW Hameeteman, D M v d Boomgaard, W Dekker, et al.European Journal of Clinical Investigation|October 9, 2001
Serum chromogranin A as a screening test for gastric enterochromaffin-like cell hyperplasia during acid-suppressive therapyS Sanduleanu, A De Bruïne, M Stridsberg, et al.European Journal of Clinical Investigation|February 18, 2003
Ratio between serum IL-8 and pepsinogen A/C: a marker for atrophic body gastritisS Sanduleanu, A D E Bruïne, I Biemond, et al.Digestion|November 2, 2011
Opportunistic screening of hospital staff using primary colonoscopy: participation, discomfort and willingness to repeat the procedureC A Khalid-de Bakker, D M Jonkers, W Hameeteman, et al.Italian Journal of Gastroenterology and Hepatology|February 12, 2000
Differential features of gastric cancer patients, either Helicobacter pylori positive or Helicobacter pylori negativeD Jonkers, P Houben, W Hameeteman, et al.The Netherlands Journal of Medicine|April 30, 2011
Cardiopulmonary events during primary colonoscopy screening in an average risk populationC A Khalid-de Bakker, D M Jonkers, W Hameeteman, et al.Pageof 3